Skip to main content

Vaccine politics: What's behind ICMR's strange love for private research institutions

By Shobha Shukla, Bobby Ramakant, Sandeep Pandey*
A letter dated July 2, 2020 by the Indian government’s apex medical research body ICMR (Indian Council of Medical Research) with a directive to begin and finish all human clinical trials of COVAXIN- an indigenously developed vaccine for Covid-19 by August 15, 2020 (India’s Independence Day) so that the vaccine can be launched for “public health use” on that day (preceding midnight?), has raised critical questions if science has got compromised and/ or is on its way out of the window.
ICMR gave a clarification later that the letter was intended to cut red-tapism and avoid delays. But the burning question remains: Why did ICMR, knowing very well that it is fundamentally unethical to pre-determine research outcomes and also that it is principally impossible to do a robust clinical trial in 5-6 weeks, try to force researchers to begin and finish research and make a vaccine available for “public health use” by Independence Day?
This letter stated that vaccine research is “being monitored at the topmost level of the government”. So, was it the Prime Minister's Office that made such a demand with scant regard to science? Was it not the duty of ICMR to uphold the highest levels of science and integrity and decline such unjustifiable requests?
The news initially gave us tremendous hope that ICMR is working towards producing India’s first indigenous vaccine against Covid-19. But a lot of questions remain unanswered regarding how it will deliver a safe and effective vaccine against Covid-19 as early as August 15, 2020.
There is a scientifically validated and accepted protocol for conducting clinical trials to provide strong evidence on the safety, efficacy and effectiveness of the medicine, vaccine or any other medical product under study, before it can be put to public use.
To ensure that the product under study is safe for humans (phase 1 study), and effective against a disease for the general populations and no harm to their health is caused by it (phases 2 and 3 studies), it is of utmost importance to adhere to all scientific and ethical considerations in the protocol and guidelines of the clinical trials.
As per the study design registered in CTRI (Clinical Trials Registry of India), the duration of this study (for phases 1 and 2) for COVAXIN is stated to be 1 year 3 months (15 months). In other words even if (and that is a big IF) all goes well in phases 1 and 2 human clinical trials, it will not be before September 2021 that we will learn if the vaccine is safe and effective, and ready to enter phase-3 (or for conditional roll-out like new anti-TB drug Bedaquiline while phase 3 study progresses ahead).
Human clinical trials have had a very bad history of abuses and human rights violations in the past century. That is why scientific protocols, guidelines and processes are well-established now worldwide to ensure that study/ trial participants give their informed consent to be part of the study, and all their rights are well protected and respected.
We all want a vaccine at the earliest but it is equally important to ensure science is respected and all protocols and safeguards are in place so that neither the study participants nor the general population are harmed in any way.
The vaccine candidate COVAXIN has currently cleared only animal studies (or pre-clinical stage) and human clinical trials have yet to begin. This is a very initial stage and declaring a date for its “public health use” is assuming that the clinical trial outcomes will be positive, which is principally unethical for a scientific study. Such declarations will not only raise undue expectations but can also result in complacency in implementing 'what-we-know-works' (including prevention measures) in containing the spread of the virus.
In an interview, Dr Soumya Swaminathan, WHO chief scientist and former DG of ICMR, raised serious questions about this timeline (of August 15, 2020) and cautioned that speed may be important but could not come at the cost of scientific and ethical standards.
If the ICMR is so confident of producing a vaccine within a month and a half why did it not announce such a measure in March itself so that the vaccine could have been developed at the earliest and saved much human suffering? The history of Indian medicine research is not very encouraging with only one Nobel prize in this field to Har Gobind Khorana for his research done in United States when he had become US citizen.
Why is only Bharat Biotech listed as principal investigator, trial coordinator, primary sponsor (there is no other secondary sponsor), source of monetary support, scientific query lead?
Another important question is that though the strain of coronavirus was isolated by ICMR National Institute of Virology, then why is a government entity not doing further research and development of the vaccine? Why (as per the letter of ICMR) has it joined hands with a private biotech company (Bharat Biotech) for preclinical and clinical research development of the vaccine? 
If it is joint research of ICMR and Bharat Biotech then why is only Bharat Biotech listed as the Principal Investigator, trial coordinator, primary sponsor (there is no other secondary sponsor), source of monetary or material support, scientific query lead, etc.?
If a private company (let’s say a soft drink company) is the only sponsor, funder, principal investigator etc of a research which shows benefit of its product, then will we not call it junk science? Also, it is important to note that no ICMR institute is included in the list of the 12 centres of this multi-centric study. Instead, we see a host of private centres too.
Why is ICMR not collaborating with only public healthcare institutions when it is the public healthcare centres that have been majorly managing Covid-19 and non-Covid-19 illnesses since the lockdown? Also, why has the government not leveraged the Epidemic Act to nationalize all health services including biotechs?
We should remember that right at the onset of lockdown in India, ICMR had landed itself in a controversy of negotiating a maximum price cap for private sector for Covid-19 test which was way high, allowing private sector to reap profits when the nation was reeling under a public health emergency and cascading humanitarian crisis.
With this background, ICMR must come out clean on intellectual property and price negotiations, if at all the vaccine sees the light of the day. In addition to this, the government of India must fully support the proposal of government of Costa Rica, for the development of a ‘global Covid-19 commons’ for all research, data, technology, treatments and vaccines relating to Covid-19 as a non-proprietary shared global resource.
While ensuring that there is no avoidable delay in scientific research, ICMR should not forget that it is also the vanguard for protecting the integrity of science and scientific rigour in the country.
In 2015 only 62% of newborn children received basic vaccinations in India. It is important to realize that vaccine-preventable illnesses are a significant cause of unnecessary human suffering and untimely deaths. We have failed to ensure zero-delay in making even the existing healthcare technologies (diagnostics, drugs, vaccines and other healthcare lifesaving procedures and care) available to everyone.
While ICMR must ensure absolute adherence to all scientific norms and standards in conducting all research studies, the government also has to ensure that once these scientific breakthroughs come out of the research pipeline, they reach the people in need without any delay – where the ‘last person in the queue’, as per Mahatma Gandhi’s talisman, must come first.
---
*Shobha Shukla is the founding head of Citizen News Service; Sandeep Pandey, a Magsaysay award winning social activist, is national vice president of Socialist Party (India); Bobby Ramakant is both with CNS and Socialist Party (India)

Comments

TRENDING

Nirma varsity demand for higher fees 'illegal', violates Article 14: Letter to Gujarat HC

Counterview Desk
Students of Gujarat’s top private institute, Nirma University, situated in the outskirts of Ahmedabad, in a letter to the Chief Justice the state High Court, have complained that the authorities are demanding “full fees” from students, without taking into account the “disproportionate impact” the lockdown has on the livelihood of students and families.

Buddhist shrines massively destroyed by Brahmanical rulers in "pre-Islamic" era: Historian DN Jha's survey

By Our Representative
Prominent historian DN Jha, an expert in India's ancient and medieval past, in his new book, "Against the Grain: Notes on Identity, Intolerance and History", in a sharp critique of "Hindutva ideologues", who look at the ancient period of Indian history as "a golden age marked by social harmony, devoid of any religious violence", has said, "Demolition and desecration of rival religious establishments, and the appropriation of their idols, was not uncommon in India before the advent of Islam".

Vulnerable to Covid-19, sharp rise in murder of Indian journalists during pandemic

By Nava Thakuria*
Vulnerability of working journalists in India is no way an alien issue as the populous country loses a number of working journalists to assailants as also medical emergencies. Even though there was only one casualty in the Indian media fraternity during the first half of 2020, who was targeted for journalistic work, India has begun witnessing an alarming number of media casualties during the Covid-19 pandemic.

Govt 'assures' Gujarat HC no action against MBBS students defying corona sahayak order

By Our Representative
The Gujarat government has assured the High Court that no action would be taken against Part-I and Part-II MBBS students of the Ahmedabad Municipal Corporation (AMC)-controlled NHL Medical College and LG Hospital and Medical College. The assurance follows the direction by Justice SH Vora to the State government not to prosecute or initiate action against the students who were defying the college authorities’ order to work as corona sahayaks (helpers).

Renounced US citizenship to serve workers, tribals, Sudha Bharadwaj 'odiously' in jail

By Atul, Sandeep Pandey*
Professor Sudha Bharadwaj has been in jail since August 2018. She was taken into police custody on August 26, 2018 on suspicion of being involved in Maoist terror activities after Republic TV claimed that she had allegedly written a letter to Maoists and was conspiring to create public disorder and unrest in India.

Cruel legacy of Green Revolution? Covid-19 underscores 'risky, fragile' food system

By Moin Qazi*  The Covid-19 crisis has highlighted the risks of an unhealthy diet and the extreme fragility of food systems. The economic reconstruction that will follow the pandemic is the perfect opportunity to provide better nutrition and health to all. The pandemic should spur us to redefine how we feed ourselves, and agricultural research can play a vital role in making our food systems more sustainable and resilient.

Plant organic, eat fresh: Emlen Bage's journey from migrant labour to agri-entrepreneur

By Chandrashekar and Kriti*
Who is a farmer? Type this question in the google search and check out the images? You can see men thronging the screen. This is the popular perception around the globe. Well one can understand how difficult it would be for a woman to defy this perception.

High youth unemployment: India 'fails' to take advantage of demographic dividend

By Varun Kumar
As coronavirus pandemic continues amplifying challenges among youth with regard to employment opportunities, government policies have further resulted in economic slowdown, leading to mass unemployment and loss jobs. According to the International Labour Organisation report “Covid-19 and the World of Work” (May 27, 2020), around 94 percent of the world’s workers are living in countries with some sort of workplace closure measures in place.

Dichotomy? US Hindutva groups oppose racism, mum on Modi's 'anti-minority' stance

By Our Representative
The Hindus for Human Rights (HHR), a US-based advocacy group, has noticed a major dichotomy between the stance taken by RSS’ US arm, Hindu Swayamsewak Sangh (HSS), expressing “shock” at the “painful killing of George Floyd, Breonna Taylor, Ahmaud Arbery, and so many others”, all of which suggest “the tragic tale of racial injustice” in US, and HSS’ “hatred” for India’s religious minorities and Dalits.